Home > NRC Library > ADAMS Public Documents

637386 Consent Letter (Change of Control) for POINT Biopharma USA Inc. to License No. 13-35593-01

Accession Number: ML23318A052

Date Released: Monday, November 20, 2023

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML23277A062 - Point Biopharma USA Inc. - Change of Control for License No. 13-35593-01 (13 page(s), 10/3/2023)
• ML23318A045 - 637386 Consent Letter (Change of Control) for POINT Biopharma USA Inc. to License No. 13-35593-01 (3 page(s), 11/13/2023)